| HLA-DPB2 |
|
major histocompatibility complex, class II, DP beta 2 (pseudogene)
|
|
|
0.743 |
0.500 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| KIR2DL2 |
P43627
|
killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 2
|
Receptor
|
|
0.612 |
0.654 |
| KIR2DS1 |
Q14954
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1
|
Receptor
|
|
0.537 |
0.769 |
| KIR2DS3 |
Q14952
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 3
|
Receptor
|
|
0.716 |
0.423 |
| MMP12 |
P39900
|
matrix metallopeptidase 12
|
Enzyme
|
|
0.484 |
0.885 |
| MS |
|
multiple sclerosis
|
|
|
0.599 |
0.692 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| RNASE3 |
P12724
|
ribonuclease A family member 3
|
|
|
0.490 |
0.808 |
| SRY |
Q05066
|
sex determining region Y
|
Transcription factor
|
|
0.456 |
0.808 |
| TRB |
P0DSE2
|
T cell receptor beta locus
|
|
|
0.636 |
0.538 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| H4C14 |
P62805
|
H4 clustered histone 14
|
|
|
0.541 |
0.692 |
| FAM215A |
Q9Y5M1
|
family with sequence similarity 215 member A
|
|
|
0.650 |
0.500 |
| TRBV28 |
A0A5B6
|
T cell receptor beta variable 28
|
|
|
0.890 |
0.192 |
| TRBV20-1 |
A0A075B6N2
|
T cell receptor beta variable 20-1
|
|
|
0.821 |
0.346 |
| TRBV3-1 |
A0A576
|
T cell receptor beta variable 3-1
|
|
|
0.890 |
0.192 |
| MBL3P |
|
mannose-binding lectin family member 3, pseudogene
|
|
|
0.518 |
0.769 |
| SPZ1 |
Q9BXG8
|
spermatogenic leucine zipper 1
|
|
|
0.507 |
0.769 |
| DBA2 |
|
Diamond-Blackfan anemia 2
|
|
|
0.599 |
0.731 |
| HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |
| LINC01193 |
|
long intergenic non-protein coding RNA 1193
|
|
|
0.565 |
0.692 |